Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00483353|
Recruitment Status : Completed
First Posted : June 7, 2007
Last Update Posted : June 17, 2008
|Condition or disease||Intervention/treatment||Phase|
|Seasonal Allergic Rhinitis||Procedure: Intra-nasal allergen challenge with Phleum pratense. Procedure: Collection of nasal effluent using filter paper. Procedure: Measurement of nasal congestion using acoustic rhinometry.||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||6 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Pilot Study to Explore the Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers in Subjects With Seasonal Allergic Rhinitis|
|Study Start Date :||July 2007|
- Post allergen challenge nasal inflammatory markers at 1, 5, 15, 30, 45 min, 1, 2, 3, 4, 5, 6, 7, 8 hours post allergen challenge.
- Post allergen challenge effects on acoustic rhinometry and symptoms at 16, 31, 45 min, 1, 2, 3, 4, 5, 6, 7, 8 hours post allergen challenge.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00483353
|Pfizer Investigational Site|
|London, England, United Kingdom, SW3 6HP|
|Study Director:||Pfizer CT.gov Call Center||Pfizer|